Insider Trading July 6, 2026 07:18 PM

Qualys Executive Moves and Corporate Developments

CFO's planned stock sale coincides with federal security milestone and analyst rating shifts

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
QLYS

Qualys, Inc. (NASDAQ:QLYS) reported that Chief Financial Officer Kim Joo Mi executed a stock sale worth $138,419 on July 2, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction involved 965 shares at $143.44 per share, leaving Ms. Kim with a direct holding of 81,215 shares. Recent corporate updates include the TotalCloud solution achieving FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency, extending federal cloud security capabilities. Analyst activity shows mixed signals: RBC Capital raised its price target to $90, JPMorgan upgraded the rating to Neutral, while Scotiabank lowered its target to $100 citing billing concerns. The stock currently trades at $158.26, near its 52-week high of $159.35, with gross profit margins reported at 83% and an overall financial health score rated as GREAT.

Qualys Executive Moves and Corporate Developments
QLYS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CFO Kim Joo Mi sold 965 shares for $138,419 under a Rule 10b5-1 plan established in August 2025, retaining 81,215 shares.
  • TotalCloud solution achieves FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency, enabling federal and regulated industry access.
  • Analyst views diverge: RBC Capital raises target to $90, JPMorgan upgrades to Neutral, while Scotiabank cuts target to $100 on billing concerns.

Kim Joo Mi, serving as Chief Financial Officer for Qualys, Inc. (NASDAQ:QLYS), completed a transaction involving the sale of company equity on July 2, 2026. The filing indicates the sale generated proceeds totaling $138,419. This activity was executed through the disposal of 965 shares of Qualys common stock, priced at $143.44 per unit. Following this disposition, Ms. Kim maintains a direct ownership stake in 81,215 shares of the company's common stock. The transaction was structured under a Rule 10b5-1 trading plan, which the reporting individual established on August 12, 2025.

Market data reflects that Qualys shares have experienced notable appreciation since the transaction date. The stock is currently valued at $158.26, positioning it close to its 52-week peak of $159.35. Financial metrics from InvestingPro highlight the company's operational efficiency, noting gross profit margins of 83%. The platform assigns an overall financial health score described as GREAT to the enterprise. Valuation models from the same source suggest the equity remains slightly undervalued relative to current trading levels.

Corporate developments have drawn investor focus recently. Qualys announced that its TotalCloud solution has secured FedRAMP High Authorization. This certification was sponsored by the U.S. Drug Enforcement Agency. The authorization expands the FedRAMP High status previously held by the Qualys Government Platform. This expansion permits federal agencies and industries subject to strict regulatory frameworks to utilize the company's cloud security infrastructure.

Analyst perspectives on the cybersecurity provider present a mixed outlook. RBC Capital increased its price target for Qualys to $90, an upward revision from $85. The firm cited solid business momentum and heightened demand for the company's product offerings as primary drivers for the adjustment. Conversely, Scotiabank reduced its price target to $100, down from $135. The bank cited concerns regarding the company's billings outlook as the rationale for the downgrade. JPMorgan adjusted its rating on Qualys stock to Neutral from Underweight. The upgrade highlighted growth within the vulnerability management category as a significant factor influencing the decision.

Qualys operates within the cybersecurity sector, a market segment sensitive to regulatory compliance and federal contracting opportunities. The FedRAMP High Authorization directly impacts the federal government and highly regulated industries by expanding access to secure cloud solutions. Analyst rating changes reflect broader market assessments of revenue visibility and growth sustainability in the technology sector. The CFO's stock sale, while executed under a pre-arranged plan, is monitored by investors as a signal of internal capital allocation decisions. The company's strong gross margins and financial health score suggest operational resilience, though billing outlook concerns noted by Scotiabank introduce uncertainty regarding near-term revenue recognition. The stock's proximity to its 52-week high indicates strong recent momentum, while valuation models suggest potential room for appreciation. Investors track these metrics alongside corporate security milestones to assess long-term positioning in the cloud security landscape.

Risks

  • Scotiabank cites concerns about the company's billings outlook, introducing uncertainty regarding near-term revenue visibility.
  • Analyst divergence reflects mixed market sentiment, with price targets ranging from $90 to $135, indicating valuation disagreement.
  • Regulatory compliance dependencies in the cybersecurity sector may impact federal adoption rates and contract sustainability.

More from Insider Trading

Snowflake Director Benoit Dageville Offloads $48.6M in Shares Amid Valuation Concerns Jul 6, 2026 Palisade Bio Director Robert Baltera Jr. Expands Position as FDA Clears Phase 2 Trial Jul 6, 2026 Sight Sciences CTO David Badawi Offloads $40,858 in Company Stock Jul 6, 2026 Sight Sciences Executive Sells Stock to Cover Tax Obligations Jul 6, 2026 Sight Sciences CLO Jeremy Hayden Sells $70,133 in Stock Jul 6, 2026